Utah Innovation Fund — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Inherent Biosciencesinherentbio.cominAug 2022
Inherent Biosciences uses AI to analyze epigenetic patterns in sperm to diagnose and predict fertility outcomes such as male infertility, sperm age, embryo quality, and azoospermia.
AI & Machine LearningBiotechDigital HealthSalt Lake City, US
Andrew Olson(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.